Form D · Biotechnology

MIRACULINS INC

Winnipeg, A2 · CIK 0001584322

Offering snapshot reported May 1, 2015 · SEC filing

Reported sold
$20.4K
Offering amount: $51K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 22, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 1, 2015Initial$20,408No comparison1SEC filing
Jan 5, 2015Initial$0No comparison1SEC filing
Aug 13, 2013Initial$888,716No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-238980
Units, consisting of 250,000 common shares and 250,000 warrants, at CAD$0.10/Unit, converted at US$0.8163. There is no guarantee that the warrants exercisable at CAD$0.15/share by April 22, 2017, will be exercised.

Source: Form D, filed May 1, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Harry J.F. Bloomfield Director
L. Michael Coutts Executive
P. Marcus Enns Executive
Marcus Enns Executive
Michael Evelegh Executive
James Kinley Executive
Jim Mellon Director
Paul Moreau Executive
Christopher J Moreau Director, Executive
William Roberts Director
Michael Stasiuk Director
Lisa Suennen Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6 1250 Waverley Street
Winnipeg, A2, R3T 6C6